USD 0.32
(-4.48%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 15.52 Million USD | -22.28% |
2022 | 22.64 Million USD | -18.34% |
2021 | 27.72 Million USD | -20.74% |
2020 | 34.98 Million USD | -37.62% |
2019 | 56.07 Million USD | 68.86% |
2018 | 33.21 Million USD | 70.62% |
2017 | 19.46 Million USD | 176.65% |
2016 | 7.03 Million USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 2.69 Million USD | -0.92% |
2024 Q2 | 2.27 Million USD | 3.75% |
2023 Q2 | 1.54 Million USD | -85.21% |
2023 Q1 | 10.47 Million USD | 29.11% |
2023 FY | 17.59 Million USD | -22.28% |
2023 Q4 | 2.71 Million USD | -4.87% |
2023 Q3 | 2.85 Million USD | 84.44% |
2022 Q1 | 5.41 Million USD | -31.62% |
2022 FY | 22.64 Million USD | -18.34% |
2022 Q4 | 8.11 Million USD | 91.28% |
2022 Q3 | 4.24 Million USD | -12.95% |
2022 Q2 | 4.87 Million USD | -10.06% |
2021 Q2 | 6.75 Million USD | -2.47% |
2021 Q4 | 7.92 Million USD | 10.75% |
2021 FY | 27.72 Million USD | -20.74% |
2021 Q3 | 7.15 Million USD | 5.83% |
2021 Q1 | 6.93 Million USD | -32.64% |
2020 FY | 34.98 Million USD | -37.62% |
2020 Q2 | 9.84 Million USD | 29.93% |
2020 Q4 | 10.28 Million USD | 41.61% |
2020 Q3 | 7.26 Million USD | -26.24% |
2020 Q1 | 7.58 Million USD | -20.04% |
2019 Q3 | 17.07 Million USD | 15.59% |
2019 Q2 | 14.76 Million USD | 0.05% |
2019 Q1 | 14.76 Million USD | -8.08% |
2019 FY | 56.07 Million USD | 68.86% |
2019 Q4 | 9.48 Million USD | -44.47% |
2018 Q2 | 8.63 Million USD | 195.28% |
2018 FY | 33.21 Million USD | 70.62% |
2018 Q4 | 16.05 Million USD | 187.26% |
2018 Q1 | 2.92 Million USD | -13.31% |
2018 Q3 | 5.59 Million USD | -35.28% |
2017 Q4 | 3.37 Million USD | 45.62% |
2017 Q2 | 11.65 Million USD | 448.49% |
2017 Q1 | 2.12 Million USD | 0.0% |
2017 Q3 | 2.31 Million USD | -80.11% |
2017 FY | 19.46 Million USD | 176.65% |
2016 FY | 7.03 Million USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Perspective Therapeutics, Inc. | 17.42 Million USD | 10.926% |
Electromed, Inc. | 35.14 Million USD | 55.834% |
Senseonics Holdings, Inc. | 78.69 Million USD | 80.275% |
Xtant Medical Holdings, Inc. | 65.62 Million USD | 76.347% |